Type 2 diabetes is becoming morecommon among youth, in parallelwith the increasing prevalence of obesity in pediatrics. Despite this, thera-peuticmodalities remain extremely limited, with scanty data regarding appropriate treatment, desired glycemic targets, and management of associated comorbidities and complications. Management of type 2 diabetes in youth, both acute and long term, should occur in specialty tertiary care pediatric centers. Health care pro-viders should address the pathophysio-logical components of insulin resistance and decline in b-cell function, aiming to preserve the latter while improving the former. Addressing comorbidities, namely
No takes yet. Share an insight, caveat, or question.
Flint et al. (2011) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: